Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions. The company develops clinical- and preclinical-stage therapies, with a product pipeline that includes...
Q1 2026
May 27, 2026
FY 2025
Dec 31, 2025
Q1 2025
Mar 31, 2025